High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial
- DOI
- 10.1016/s1470-2045(26)00277-9
- Published
- 2026-09
- Container
- The Lancet Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-26-00277-9,
title = {High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial},
author = {Christophe Hennequin and Paul Sargos and Lise Roca and Marion Silva and Igor Latorzeff and Didier Peiffert and Salvatore Cozzi and Ahmed Benyoucef and Ali Hasbini and Stéphane Supiot and Philippe Ronchin and Thierry Wachter and David Azria and Nicolas Magne and Mallik Zibouche and Nicolas Vial and Luc Cormier},
year = {2026},
journal = {The Lancet Oncology},
doi = {10.1016/s1470-2045(26)00277-9},
url = {https://doi.org/10.1016/s1470-2045(26)00277-9}
}RIS
TY - JOUR TI - High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial AU - Christophe Hennequin AU - Paul Sargos AU - Lise Roca AU - Marion Silva AU - Igor Latorzeff AU - Didier Peiffert AU - Salvatore Cozzi AU - Ahmed Benyoucef AU - Ali Hasbini AU - Stéphane Supiot AU - Philippe Ronchin AU - Thierry Wachter AU - David Azria AU - Nicolas Magne AU - Mallik Zibouche AU - Nicolas Vial AU - Luc Cormier PY - 2026 JO - The Lancet Oncology DO - 10.1016/s1470-2045(26)00277-9 UR - https://doi.org/10.1016/s1470-2045(26)00277-9 ER -
APA
Hennequin, C., Sargos, P., Roca, L., Silva, M., Latorzeff, I., Peiffert, D., Cozzi, S., Benyoucef, A., Hasbini, A., Supiot, S., Ronchin, P., Wachter, T., Azria, D., Magne, N., Zibouche, M., Vial, N., & Cormier, L. (2026). High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(26)00277-9
Source records
- crossref · retrieved 2026-09-25T19:42:24.595Z